- Home >
- Life Sciences >
- Biotechnology >
Biotechnology Industry Analysis and Statistics (since 2008 - p4)
All premium reports for Biotechnology Industry Analysis and Statistics (since 2008 - p4)
91-120 of 286 Premium Reports from 27 Publishers
Osiris Therapeutics, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Osiris Therapeutics, Inc. - Financial and Strategic Analysis ReviewSummaryOsiris Therapeutics, Inc. (Osiris) is an independent biotechnology company that commercializes stem cell therapeutic products taken from the adult bone marrow. The company is involved in development and sale of various product ...
Industries : Biotechnology
BioTime, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
BioTime, Inc. - Financial and Strategic Analysis ReviewSummaryBioTime is a biomedical company involved in the research and development of synthetic solutions that are used as blood plasma volume expanders, blood replacement solutions during hypothermic (low temperature) surgery, and organ preservati ...
Industries : Biotechnology
CryoLife, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
CryoLife, Inc. - Financial and Strategic Analysis ReviewSummaryCryoLife, Inc. (CryoLife) is a biomedical company that develops and commercializes biomaterials, implantable medical devices, and also preserves and distributes human tissues for cardiovascular and vascular transplant applications. The c ...
Industries : Biotechnology
Aastrom Biosciences, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Aastrom Biosciences, Inc. - Financial and Strategic Analysis ReviewSummaryAastrom Biosciences (Aastrom) is a regenerative medicine company, which is engaged in the development of autologous cell products for use in regenerative medicine. The company?s principal business is to develop Tissue Repair C ...
Industries : Biotechnology
Ablynx NV - Financial and Strategic Analysis Review
- $ 125
- April 2009
Ablynx NV - Financial and Strategic Analysis ReviewSummaryAblynx NV (Ablynx) is engaged in the discovery and development of Nanobodies, for treating human diseases that are serious and life-threatening. Nanobodies are a novel class of antibody-derived therapeutic proteins, which have the advantages ...
Industries : Biotechnology
Cepheid - Financial and Strategic Analysis Review
- $ 125
- April 2009
Cepheid - Financial and Strategic Analysis ReviewSummaryCepheid is a molecular diagnostic company. It is engaged in the development, manufacture and marketing of fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. These systems allow rapid and s ...
Industries : Biotechnology
deCODE genetics, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
deCODE genetics, Inc. - Financial and Strategic Analysis ReviewSummarydeCODE genetics, Inc. (decode) is a biopharmaceutical company. It is principally engaged in applying its discoveries pertaining to human genetics and developing drugs and diagnostics towards the cure and prevention of common disea ...
Industries : Biotechnology
AspenBio Pharma, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
AspenBio Pharma, Inc. - Financial and Strategic Analysis ReviewSummaryAspenBio Pharma, Inc. (AspenBio) is an emerging biotechnology company that is principally engaged in the discovery, development, manufacture, licensing and marketing of products for human and animal healthcare. The company's key c ...
Industries : Biotechnology
Genomic Health, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Genomic Health, Inc. - Financial and Strategic Analysis ReviewSummaryGenomic Health, Inc. (Genomic Health) is a life science company that is principally engaged in conducting genomic research to develop and commercialize clinically approved molecular diagnostics and laboratory services for cancer. T ...
Industries : Biotechnology
Illumina, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Illumina, Inc. - Financial and Strategic Analysis ReviewSummaryIllumina, Inc., is a Molecular Diagnostics company. The company is principally focused into research and developement of DNA and RNA Assays. It develops, manufactures and markets integrated systems for the analysis of genetic variation a ...
Industries : Biotechnology
Covance Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Covance Inc. - Financial and Strategic Analysis ReviewSummaryCovance Inc. (Concave) is a healthcare company. It is engaged in the manufacture and development of biotechnological integrated product services, drug development and other related products. The company also develops and carries out precli ...
Industries : Biotechnology
Cytori Therapeutics, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Cytori Therapeutics, Inc. - Financial and Strategic Analysis ReviewSummaryCytori Therapeutics, Inc. (Cytori Therapeutics) is engaged in the development and commercialization of stem and regenerative cell therapies. The products manufactured are used towards the treatment of cardiovascular disease, ...
Industries : Biotechnology
Inovio Biomedical Corporation - Financial and Strategic Analysis Review
- $ 125
- April 2009
Inovio Biomedical Corporation - Financial and Strategic Analysis ReviewSummaryInovio Biomedical Corporation (Inovio) is a biomedical company, which is engaged in the development of next-generation vaccines and immunotherapies using its proprietary Electroporation Therapy (EPT) technology. The compan ...
Industries : Biotechnology
Accelrys, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Accelrys, Inc. - Financial and Strategic Analysis ReviewSummaryAccelrys, Inc. (Accelrys) is engaged in the development and marketing of scientific business intelligence software for the aggregation, mining, integration, analysis, simulation, management and interactive reporting of scientific data. T ...
Industries : Software, Biotechnology, Business Services
Avigen, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Avigen, Inc. - Financial and Strategic Analysis ReviewSummaryAvigen, Inc. (Avigen) is a biopharmaceutical company engaged in the development and commercialization of small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The compan ...
Industries : Biotechnology
Advanced Cell Technology, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Advanced Cell Technology, Inc. - Financial and Strategic Analysis ReviewSummaryAdvanced Cell Technology, Inc. (ACT) is engaged in the development and commercialization of the human embryonic stem cell technology in the field of regenerative medicine. The company's business is employed in developing ...
Industries : Biotechnology
Bioniche Life Sciences - Financial and Strategic Analysis Review
- $ 125
- April 2009
Bioniche Life Sciences - Financial and Strategic Analysis ReviewSummaryBioniche Life Sciences Inc. (Bioniche) is a research-based Canadian biopharmaceutical company. The company is focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health ...
Industries : Biotechnology
Commonwealth Biotechnologies, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Commonwealth Biotechnologies, Inc. - Financial and Strategic Analysis ReviewSummaryCommonwealth Biotechnologies, Inc. (CBI) is a specialized life sciences company engaged in providing macromolecular synthetic and analytical technologies in the areas of bio-defense, laboratory support, and contract ...
Industries : Biotechnology
Halozyme Therapeutics - Financial and Strategic Analysis Review
- $ 125
- April 2009
Halozyme Therapeutics - Financial and Strategic Analysis ReviewSummaryHalozyme Therapeutics, a biopharmaceutical company is engaged in the development and commercialization of products targeting the extracellular matrix for the drug delivery, oncology, dermatology and endocrinology markets. Its prod ...
Industries : Biotechnology
Access Pharmaceuticals - Financial and Strategic Analysis Review
- $ 125
- April 2009
Access Pharmaceuticals - Financial and Strategic Analysis ReviewSummaryAccess Pharmaceuticals, Inc. (Access Pharmaceuticals) is a biopharmaceutical company focused on developing products based upon its nanopolymer chemistry technologies. The company also focuses upon oncology and provides supportive ...
Industries : Biotechnology
Neurocrine Biosciences, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Neurocrine Biosciences, Inc. - Financial and Strategic Analysis ReviewSummaryNeurocrine Biosciences, Inc is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative pharmaceutical products for treatment of neurological and endocrine-related diseases and d ...
Industries : Biotechnology
Biotron Limited - Financial and Strategic Analysis Review
- $ 125
- April 2009
Biotron Limited - Financial and Strategic Analysis ReviewSummaryBiotron Limited (Biotron) is a biotechnology company. The company is primarily engaged in funding and management of intermediate and applied biotechnology research and development projects. The company was incorporated in 1999. It is he ...
Industries : Biotechnology
Antigenics, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Antigenics, Inc. - Financial and Strategic Analysis ReviewSummaryAntigenics Inc. (Antigenics) is a biotechnology company. The company is focused on the developing superior health care products and technologies for a wide range of cancers, infectious diseases and autoimmune disorders based on immunol ...
Industries : Biotechnology
GPC Biotech AG - Financial and Strategic Analysis Review
- $ 125
- April 2009
GPC Biotech AG - Financial and Strategic Analysis ReviewSummaryGPC Biotech AG is a biopharmaceutical company engaged in the discovery, development and commercialization of new drugs to treat cancer drugs. The company has various anti-cancer programs in research and development that leverage its prof ...
Industries : Biotechnology
Gilead Sciences, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Gilead Sciences, Inc. - Financial and Strategic Analysis ReviewSummaryGilead Sciences, Inc. (Gilead) is a biopharmaceutical company that principally engaged in discovering, developing and commercializing medicines in unmet medical need areas. The company mainly focuses on antivirals, cardiovascular ...
Industries : Biotechnology
Alkermes, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Alkermes, Inc. - Financial and Strategic Analysis ReviewSummaryAlkermes, Inc., (Alkermes) a biotechnology company, develops, and manufactures extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addictio ...
Industries : Biotechnology
Generex Biotechnology Corporation - Financial and Strategic Analysis Review
- $ 125
- April 2009
Generex Biotechnology Corporation - Financial and Strategic Analysis ReviewSummaryGenerex Biotechnology Corporation (Generex) is engaged in the research, development, manufacture and commercialization of drug delivery systems and technologies. The company focuses on drug delivery system of large mol ...
Industries : Biotechnology
Albany Molecular Research, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Albany Molecular Research, Inc. - Financial and Strategic Analysis ReviewSummaryAlbany Molecular Research Inc (AMRI) is engaged in drug discovery and development of novel biologically small molecules for application in the drug market. The company focuses on chemistry research, drug discovery, optim ...
Industries : Biotechnology
Advanced Viral Research Corp. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Advanced Viral Research Corp. - Financial and Strategic Analysis ReviewSummaryAdvanced Viral Research Corp. (Advanced Viral) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule anti-cancer drugs. The company holds 14 United States patents, and ...
Industries : Biotechnology
Alchemia Limited - Financial and Strategic Analysis Review
- $ 125
- April 2009
Alchemia Limited - Financial and Strategic Analysis ReviewSummaryAlchemia Limited (Alchemia) is an Australian biotechnology company. The company focused on its chemistry expertise. The company?s lead program is fondaparinux for the prevention of deep vein thrombosis. Its operations are carried out i ...
Industries : Biotechnology
reportlinker.com © Copyright 2009. All rights reserved